Announcements (as of April 2023)

Announcements (as of April 2023)

  • Transitions aren’t goodbyes!
    As many of you know, Emily Ali’s last full day in the Molecular Epidemiology Lab will be Thursday, April 20th, 2023, but you can email her regarding Epidemiology studies till Friday April 21st.Among other contributions, Emily is central to Jun Mao’s Study “Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment and Genetic Susceptibility to Cancer Related Cognitive Dysfunction in Women undergoing Treatment for Breast Cancer studies” and the “MSK Pancreatic Family Registry” led by Margaret Du.  Emily will be transitioning to Pathology and become a team member of the Gynecology DMT Research Laboratory led by Britta Weigelt.

    Emily, we will miss your spark! Thank you for all your contributions to our Research Program. We wish you much success in the new position.  

    With warm regards, 
    Irene & the Molecular Epi Lab mates & friends


  • Since June 2022, we are temporarily residing at 327 East 64th Street, 4th floor, Room 411 (2nd and 3rd bays) until the construction of our larger Lab is finalized in Main Campus, on Schwartz S10. We anticipate moving back in the Fall, 2023. Email us as usual, the current phone numbers are updated within the ‘Get in Touch’ section.
  • As usual, to allow us to process and test quality biospecimens, and produce meaningful data, stay in touch regarding potential or confirmed incoming participants’ samples collected under the IRB protocols listed below. Studies with active accrual and biospecimens collection:
    • #10-079 (‘TLC’) 
    • #02-102 (‘PAN’) 
    • #20-124 (‘ENHANCE’) 
    • #17-007 (‘InterMEL’) 
    • #17-500 (‘CASTL’) 
    • #18-240 (‘Leverage’)
    Additional specimens/ biocollections are being QC’d or tested for studies closed for accrual, open for analyses.


  • We look forward welcoming our 2023 Summer Interns!
    Uma P. (McGill University, Montreal; class of 2026)
    Sophia D. (Philips Academy, MA; rising Junior)